Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Work with Us
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Work with Us
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Search type
Keyword
Author
Edition
European
US
Hepatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Interviews
Podcasts
Videos & Webinars
News
Infographics
Society updates
Submit A Paper
MASLD Survival Link in Liver Cancer Varies With BMI
October 2026
A survival advantage linked to MASLD disappeared after matching, while BMI subgroup analyses suggested differing outcomes.
Read more
30 Oct 2026
MASLD Survival Link in Liver Cancer Varies With BMI
A survival advantage linked to MASLD disappeared after matching, while BMI subgroup analyses suggested differing outcomes.
28 Oct 2026
Radiotherapy Highlights Local Risks in Bile Duct Cancer
A retrospective study found that radiotherapy provided local control in unresectable extrahepatic bile duct cancer, while cholangitis, liver failure, and tumour bleeding contributed to at least 40% of deaths.
25 Oct 2026
Clinical Model Predicts Outcomes in Unresectable Liver Cancer
A multicentre study developed and validated a FIT model combining fibrin degradation products, serum iron, and tumour burden score to predict survival in patients with unresectable hepatocellular carcinoma receiving combined therapy.
23 Oct 2026
Opinion: Beyond Congress – Bringing Liver Health into the Community
Around 700 people received free liver health checks during UEG Week 2026 in Barcelona through the Love Your Liver initiative, highlighting the role of accessible screening, early detection and public health awareness in tackling liver disease.
23 Oct 2026
GDF15 Protects Against Alcohol-Associated Liver Disease
GDF15 may protect against alcohol-associated liver disease by suppressing neutrophil glycolysis, inflammation, and liver injury.
21 Oct 2026
MASLD Mortality Risk Rises with Stress and Unhealthy Behaviours
A study of 9,761 adults linked high allostatic load and unhealthy behaviours to increased all-cause and cardiovascular mortality among participants with MASLD.
19 Oct 2026
CT for prediction of nuclear β-catenin expression in HCC
CT radiomics and tumour heterogeneity predict β-catenin expression in hepatocellular carcinoma.
16 Oct 2026
AI Model Improves Liver Cancer Detection in Hepatitis B
An AI model combining ctDNA methylation and clinical data achieved an AUC of 0.903 for detecting liver cancer in patients with hepatitis B.
Loading posts...
1
2
3
…
56
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View